Dong-A ST Co., Ltd. 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-16 4:46 pm Sale | 2022-09-14 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | Dong-A ST Co., Ltd. | 12,003 10.700% | -0 (-0.00%) | Filing |
| 2021-09-01 4:20 pm Unchanged | 2021-09-01 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | Dong-A ST Co., Ltd. | 12,003 12.900% | 0 (Unchanged) | Filing |
| 2021-08-27 9:11 pm Unchanged | 2021-08-27 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | Dong-A ST Co., Ltd. | 12,003 12.900% | 0 (Unchanged) | Filing |
| 2021-03-11 06:08 am Unchanged | 2021-03-09 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | Dong-A ST Co., Ltd. | 12,003 13.000% | 0 (Unchanged) | Filing |